期刊文献+

人肝微粒体内红霉素等药物对西尼地平代谢的影响 被引量:1

Metabolic Interaction of Cinildipine with Some Co-administrated Drugs in Human Liver Microsomes
在线阅读 下载PDF
导出
摘要 目的用人肝微粒体研究部分临床常用的药物对西尼地平代谢的影响。方法采用HPLC方法测定西尼地平及其代谢物,色谱柱为HypersilC18柱(250mm×46mmID,5μm),流动相为乙腈甲醇001mol/L四丁基溴化铵溶液(55∶5∶40),柱温50℃,紫外检测波长238nm。结果环孢素、红霉素和辛伐他丁可以较明显地抑制肝微粒体中西尼地平的代谢,而其他药物甲苯磺丁脲、格列齐特、格列喹酮、格列美脲、二甲双胍、卡托普利、法莫替丁对西尼地平的代谢没有明显的影响。结论研究提示环孢素、红霉素和辛伐他丁与西尼地平可能产生代谢相互作用。 AIM:To study the metabolic interaction of cinildipine with some drugs often co-administrated clinically in human liver microsomes. METHOD:Chromatographic analysis was performed on Hypersil BDS C 18 column.The mobile phase consisted of acetonitril-methanol-water containing 0.01mol/L tetrabutyl ammonium bromide(55∶5∶40,v/v/v) and the UV detection wavelength was set at 238 nm.RESULT: Cyclosporin A,erythromycin and simvastatin could significantly inhibit the metabolism of cinildipine in human liver microsomes,while such drugs as tolbutamide,gliclazide,glimepiride,metformine,captopril and famotidine had no significant inhibitory effect on the metabolism of cinildipine.CONCLUSION:The inhibitors or substrate of CYP 3A may affect the metabolism of cinildipine.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2004年第6期524-527,共4页 Journal of China Pharmaceutical University
基金 国家高技术研究发展计划(863计划)资助项目(No.2003AA2Z347A) 江苏省药代动力学重点实验室资助项目(No.BM2001201)~~
关键词 西尼地平 高效液相色谱法 肝微粒体 代谢 相互作用 Cinildipine HPLC Liver microsomes Metabolism Interaction
  • 相关文献

参考文献3

二级参考文献4

共引文献16

同被引文献26

  • 1刘友平,丁慧荣,何涛,代荣阳,李洪.一种简单、经济、高效的大量肝细胞培养方法[J].生物学通报,2005,40(1):47-48. 被引量:10
  • 2代方国,罗仁,王宇光,夏成云,谭洪玲,肖成荣,赵永红,高月.甘遂配伍甘草对大鼠肝脏CYP2E1表达及活性的影响[J].第三军医大学学报,2005,27(8):742-744. 被引量:60
  • 3CHING M S,BICHARA N,BLAKE C L,et al.Propranonol 4-and 5-hydroxylation and N -desisopropylation by cloned human cytochrome P450 1A1 and P450 1A2[J].Drug Metab Dispos,1996,24(6):692.
  • 4BICHARA N,CHING M S,BLAKE C L,et al.Propranolol hydroxylation and N-desisopropylation by cytochrome P4502D6:studies using the yeast-expressed enzyme and NADPH/O2 and cumene hydroperoxide-supported reactions[J].Drug Metab Dispos,1996,24(1):112.
  • 5YOSHIMOTO K,ECHIZEN H,CHIBA K,et al.Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers-N -desisopropylation is mediated mainly by CYP 1A2[J].Br J Clin Pharmacol,1995,39(4):421.
  • 6MASUBUCHI Y,HOSOKWA S,HORIE T,et al.Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes.The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase[J].Drug Metab Dispos,1994,22(6):909.
  • 7HENGSTLER J G,UTESCH D,STEINBERG P,et al.Cryoper-served primany hepatocytes as a constantly avaible in vitro model for the evaluation of human and animal drug metabolism and enzyme induction[J].Drug Metab Review,2000,32(1):81.
  • 8NAKAGAWA Y,SUZUKI T.Metabolism of bisphenol A in isolated rat hepatocytes and oestrogenic activity of a hydroxylated metabolite in MCF-7 human breast cancer cells[J].Xenobiotica,2001,3(3):113.
  • 9POTTENGER,DOMORADZKI L H,MANKHAM J Y,et al.The relative bioavilability and metabolism of bisphenol A in rats is dependent upon the route of administration[J].Toxicol Sci,2000,54(1):3.
  • 10SHIBATA Y,TAKAHASHI H,CHIBA M,et al.Predi-ction of hepatic clearance and availability by cryopreserved human hepatocytes:an application serum incubation method[J].Drug Metab Dispos,2002,30(8):892.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部